Jason Matuszewski, BioStem Technologies CEO, wins Entrepreneur Of The Year 2025 Florida Award.
ByAinvest
Tuesday, Jun 17, 2025 9:01 am ET1min read
ENS--
BioStem Technologies, based in Pompano Beach, Florida, specializes in placental-derived allografts using its proprietary BioREtain technology for chronic wound care. The company has been developing and manufacturing advanced wound care solutions used by clinicians nationwide. Matuszewski's leadership has been instrumental in the company's growth and success, with the recognition from EY US serving as a testament to his contributions [2].
As a Florida award winner, Matuszewski will now move on to compete for the National Awards at the Strategic Growth Forum in November 2025. Should he advance, he will represent the US in the EY World Entrepreneur Of The Year Award competition in June 2026. The Entrepreneur Of The Year Awards, founded in 1986, celebrate ambitious visionaries leading successful, dynamic businesses in the US and globally [1].
Matuszewski expressed gratitude for the recognition, attributing the success to the hard work and dedication of his team. The award winners become lifetime members of a global community, receiving ongoing access to insights and resources from EY and other ecosystem members [1].
References:
[1] https://www.ey.com/en_us/newsroom/2025/06/ey-us-winners-for-the-eoy-2025-florida-award
[2] https://www.stocktitan.net/news/BSEM/ernst-young-llp-ey-us-announces-jason-matuszewski-ceo-of-bio-stem-wbgnwqxzloiy.html
FLYY--
Jason Matuszewski, CEO of BioStem Technologies, was named an Entrepreneur Of The Year 2025 Florida Award winner by EY US. He was chosen for his long-term value creation, entrepreneurial spirit, purpose-driven commitment, and significant growth and impact. Matuszewski is honored to receive the recognition and credits it to the hard work of his team.
Jason Matuszewski, the CEO and Chairman of BioStem Technologies, has been recognized as a winner of the Entrepreneur Of The Year 2025 Florida Award by EY US. The award, which celebrates visionary leaders transforming industries and driving growth, was presented to Matuszewski for his long-term value creation, entrepreneurial spirit, purpose-driven commitment, and significant growth and impact [1].BioStem Technologies, based in Pompano Beach, Florida, specializes in placental-derived allografts using its proprietary BioREtain technology for chronic wound care. The company has been developing and manufacturing advanced wound care solutions used by clinicians nationwide. Matuszewski's leadership has been instrumental in the company's growth and success, with the recognition from EY US serving as a testament to his contributions [2].
As a Florida award winner, Matuszewski will now move on to compete for the National Awards at the Strategic Growth Forum in November 2025. Should he advance, he will represent the US in the EY World Entrepreneur Of The Year Award competition in June 2026. The Entrepreneur Of The Year Awards, founded in 1986, celebrate ambitious visionaries leading successful, dynamic businesses in the US and globally [1].
Matuszewski expressed gratitude for the recognition, attributing the success to the hard work and dedication of his team. The award winners become lifetime members of a global community, receiving ongoing access to insights and resources from EY and other ecosystem members [1].
References:
[1] https://www.ey.com/en_us/newsroom/2025/06/ey-us-winners-for-the-eoy-2025-florida-award
[2] https://www.stocktitan.net/news/BSEM/ernst-young-llp-ey-us-announces-jason-matuszewski-ceo-of-bio-stem-wbgnwqxzloiy.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet